Tetanus and Diphtheria Toxoids Adsorbed Purple Book BLA 103921

BLA number
103921
Proper names
Tetanus and Diphtheria Toxoids Adsorbed
Applicant
Sanofi Vaccines US Inc.
Center
CBER
First observed release
2022-05-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Tetanus and Diphtheria Toxoids Adsorbed351(a)2.5LF, 5LF, 2.5UG, 8UG/.5MLInjectionIntramuscularPre-Filled SyringeRxVoluntarily Revoked1999-12-09
002Tetanus and Diphtheria Toxoids Adsorbed351(a)2.5LF, 5LF, 2.5UG, 8UG/.5MLInjectionIntramuscularSingle-Dose VialRxVoluntarily Revoked1999-12-09

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2026-05-01U001Tetanus and Diphtheria Toxoids Adsorbed351(a)RxSanofi Vaccines US Inc.
2026-05-01U002Tetanus and Diphtheria Toxoids Adsorbed351(a)RxSanofi Vaccines US Inc.
2022-05-01N001Tetanus and Diphtheria Toxoids Adsorbed351(a)RxSanofi Pasteur Inc.
2022-05-01N002Tetanus and Diphtheria Toxoids Adsorbed351(a)RxSanofi Pasteur Inc.

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2022-05-01001Tetanus and Diphtheria Toxoids Adsorbed351(a)RxVoluntarily Revoked1999-12-09
2022-05-01002Tetanus and Diphtheria Toxoids Adsorbed351(a)RxVoluntarily Revoked1999-12-09